INdividualised Treatment targets for EldeRly patients using Vildagliptin Add-on or Lone therapy (INTERVAL) study

被引：0
|
作者：
Strain, W. David [1 ]
Lukashevich, V. [2 ]
Kothny, W. [2 ]
Hoellinger, M. -J. [3 ]
Paldanius, P. [3 ]
机构：
[1] Univ Exeter, Sch Med, Exeter EX4 4QJ, Devon, England
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
891
引用
收藏
页码：S354 / S355
页数：2
相关论文
共 50 条
  • [31] Observational study to evaluate the clinical benefit of lamotrigine add-on therapy in bipolar patients in a naturalistic treatment setting
    Woo, Young Sup
    Bahk, Won-Myong
    Pae, Chi-Un
    Jeong, Jong-Hyun
    Koo, Bon-Hoon
    Jon, Duk-In
    Lee, Jung Goo
    Kim, Moon-Doo
    ASIA-PACIFIC PSYCHIATRY, 2014, 6 (03) : 334 - 341
  • [32] Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study
    Rasgon, Natalie L.
    Kenna, Heather A.
    Williams, Katherine E.
    Powers, Bevin
    Wroolie, Tonita
    Schatzberg, Alan F.
    THESCIENTIFICWORLDJOURNAL, 2010, 10 : 321 - 328
  • [33] ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL
    Brennan, A.
    Gillett, M.
    Duenas, A.
    VALUE IN HEALTH, 2008, 11 (06) : A501 - A501
  • [34] Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study
    Ayvaz, Goksun
    Keskin, Lezzan
    Akin, Fulya
    Dokmetas, Hatice Sebile
    Tasan, Ertugrul
    Ar, Idilhan Baloglu
    Uren, Emel
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (04) : 623 - 632
  • [35] Comparing the safety and effectiveness of imeglimin and vildagliptin as add-on therapies in type 2 diabetes patients: A record-based study
    Samajdar, Shambo Samrat
    Gokalani, Rutul
    Biswas, Kaushik
    Saboo, Bharat
    Mukherjee, Shatavisa
    Pal, Jyotirmoy
    Joshi, Shashank
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2025,
  • [36] An initial experience of add-on therapy using perampanel for adult patients with refractory epilepsy
    Mitsueda-Ono, T.
    Kitagawa, T.
    Gotou, M.
    Suzuki, H.
    Ishimoto, T.
    Matsui, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 554 - 554
  • [37] Naturalistic study of efficacy of acute treatment with paliperidone palmitate as add-on therapy in the treatment of manic inpatients
    Nieto, E.
    Carreras, J.
    Rius, M.
    Puig, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 55 - 55
  • [38] Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients
    Caraballo, Roberto H.
    Reyes, Gabriela
    Chacon, Santiago
    Fortini, Pablo Sebastian
    EPILEPSY & BEHAVIOR, 2024, 150
  • [39] Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
    Ihara, Masafumi
    Nishino, Madoka
    Taguchi, Akihiko
    Yamamoto, Yumi
    Hattori, Yorito
    Saito, Satoshi
    Takahashi, Yukako
    Tsuji, Masahiro
    Kasahara, Yukiko
    Takata, Yu
    Okada, Masahiro
    PLOS ONE, 2014, 9 (02):
  • [40] EFFICACY AND SAFETY EVALUATION OF LORECLEZOLE AS ADD-ON TREATMENT IN THERAPY-RESISTANT EPILEPSY PATIENTS
    RENTMEESTER, T
    HULSMAN, J
    EPILEPSY RESEARCH, 1991, 8 (02) : 166 - 169
12345